Revance
Biotechnology ResearchTennessee, United States501-1000 Employees
Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences.
Insights
Market Expansion Revance has recently expanded its presence in China through partnerships with Viatris Inc. and Shanghai Fosun Pharmaceutical to develop and commercialize DAXXIFY, presenting sales opportunities in the growing Chinese healthcare market.
Product Development With the launch of DAXXIFY for cervical dystonia treatment and the development of a biosimilar to onabotulinumtoxinA injection, Revance is diversifying its product portfolio, opening up avenues for sales to new patient segments and healthcare providers.
Investment Boost Revance's recent investments from Dynamic Technology Lab Pte Ltd indicate confidence in the company's potential, highlighting opportunities for strategic partnerships and further financial support that could drive sales growth.
Competitive Positioning As a biotechnology company focusing on aesthetics and therapeutics, Revance's positioning alongside industry giants like AbbVie and Allergan presents opportunities for collaborative ventures and market differentiation to capture a share of the competitive landscape.
Market Presence With a revenue range of $100M - 1B and a strong technological stack incorporating tools like Pardot and Cloudflare CDN, Revance is well-equipped for strategic marketing campaigns and outreach efforts to enhance brand visibility and drive sales.
Similar companies to Revance
AbbVie
54K
$1BMerz Aesthetics
2.2K$100M$1BAllergan
11K$1BTEOXANE Laboratories
622$50M$100MCroma-Pharma
501$100M$1BGalderma
6.6K$1B
Revance Tech Stack
Revance uses 8 technology products and services including Akamai, jsDelivr, Zendesk, and more. Explore Revance's tech stack below.
- AkamaiContent Delivery Network
- jsDelivrContent Delivery Network
- ZendeskDocumentation Tools
- PardotMarketing
- RSSMiscellaneous
- PHPProgramming Languages
- ConcurTravel And Expense Management
- Adobe Creative SuiteVisualisation Software
Media & News
Revance's Email Address Formats
Revance uses at least 1 format(s):
| Revance Email Formats | Percentage |
| First.Last@revance.com | 54% |
| FLast@revance.com | 40% |
| FirstLast@revance.com | 5% |
| Last@revance.com | 1% |
Frequently Asked Questions
Where is Revance's headquarters located?
Revance's main headquarters is located at 1222 Demonbreun St 20th Floor Nashville, Tennessee 37203 US. The company has employees across 5 continents, including North AmericaEuropeSouth America. What is Revance's phone number?
You can contact Revance's main corporate office by phone at +1-510-742-****
What is Revance's stock symbol?
Revance is a publicly traded company; the company's stock symbol is RVNC. What is Revance's official website and social media links?
Revance's official website is revance.com and has social profiles on LinkedIn.How much revenue does Revance generate?
As of October 2024, Revance's annual revenue reached $750M. What is Revance's SIC code NAICS code?
Revance's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Revance have currently?
As of October 2024, Revance has approximately 633 employees across 5 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: M. F.Chief Financial Officer: T. T. S.Chief Scientific Officer: C. G.. Explore Revance's employee directory with LeadIQ.What industry does Revance belong to?
Revance operates in the Biotechnology Research industry. What technology does Revance use?
Revance's tech stack includes AkamaijsDelivrZendeskPardotRSSPHPConcurAdobe Creative Suite. What is Revance's email format?
Revance's email format typically follows the pattern of . Find more Revance email formats with LeadIQ. How much funding has Revance raised to date?
As of October 2024, Revance has raised $100M in funding. The last funding round occurred on Mar 04, 2024 for $100M.
Company Overview
- Headquarters
- 1222 Demonbreun St 20th Floor Nashville, Tennessee 37203 US
- Phone number
- +1-510-742-****
- Website
- revance.com
- SIC Code
- 2834 - Pharmaceutical Preparations
- Stock Symbol
- RVNC
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 501-1000
Media & News
Funding & Financials
- $100M
Revance has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100M.
- $100M$1B
Revance's revenue is in the range of $100M$1B
Funding & Financials
- $100M
Revance has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100M.
- $100M$1B
Revance's revenue is in the range of $100M$1B
Company Leadership
M. F.Chief Executive Officer
T. T. S.Chief Financial Officer- C. G.Chief Scientific Officer
D. M.Chief Legal Officer, General Counsel & Corporate Secretary- J. P.Chief Of Staff
Employee Directory
- B. S.Senior Executive Assistant To Cfo, Cmo, Cso
- D. B.President & CEO
- D. S.Founder And Principal
- D. P.Executive Assistant To Ceo
- L. S.Cfo & Executive Vice President Corporate Development
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
